SARS-CoV-2, diabetes and mortality: month by month variation in mortality rate from June 2020 to June 2021

Cardiovasc Endocrinol Metab. 2022 Jan 28;11(1):e0258. doi: 10.1097/XCE.0000000000000258. eCollection 2022 Mar.

Adrian H Heald^{1

2}, David A Jenkins^{3

4}, Nadia Chaudhury⁵, Richard Williams^{3

4}, Matthew Sperrin^{3

4}, Niels Peek^{3

4}, William Ollier^{1

6}, Kelly Bowden-Davies⁷, Gayathri Delanerolle^{8

9}, Simon G Anderson^{10

11}, John Martin Gibson^{1

2}

¹ The School of Medicine and Manchester Academic Health Sciences Centre, The University of Manchester, Manchester.
² Department of Diabetes and Endocrinology, Salford Royal NHS Foundation Trust, Salford.
³ Division of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester.
⁴ NIHR Greater Manchester Patient Safety Translational Research Centre, The University of Manchester, Manchester.
⁵ University Hospitals Coventry and Warwickshire, Coventry.
⁶ Faculty of Science and Engineering, Manchester Metropolitan University, Manchester.
⁷ Department of Sport and Exercise Sciences, Musculoskeletal Science and Sports Medicine Research Centre, Manchester Metropolitan University, Manchester.
⁸ Nuffield Department of Primary Health Care Science, University of Oxford (Substantive), Oxford.
⁹ Clinical Research Facility, Southern Health NHS Foundation Trust (Honorary), Southampton, UK.
¹⁰ The George Alleyne Chronic Disease Research Centre, University of the West Indies, Cave Hill Campus, Bridgetown, Barbados.
¹¹ Division of Cardiovascular Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.

No abstract available